GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QUIA PHARMA AB (OSTO:QUIA) » Definitions » PS Ratio

QUIA PHARMA AB (OSTO:QUIA) PS Ratio : 3.33 (As of Apr. 22, 2025)


View and export this data going back to 2005. Start your Free Trial

What is QUIA PHARMA AB PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, QUIA PHARMA AB's share price is kr0.0133. QUIA PHARMA AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00. Hence, QUIA PHARMA AB's PS Ratio for today is 3.33.

The historical rank and industry rank for QUIA PHARMA AB's PS Ratio or its related term are showing as below:

OSTO:QUIA' s PS Ratio Range Over the Past 10 Years
Min: 0.01   Med: 5.39   Max: 40.74
Current: 3.33

During the past 13 years, QUIA PHARMA AB's highest PS Ratio was 40.74. The lowest was 0.01. And the median was 5.39.

OSTO:QUIA's PS Ratio is ranked better than
72.05% of 973 companies
in the Biotechnology industry
Industry Median: 8.26 vs OSTO:QUIA: 3.33

QUIA PHARMA AB's Revenue per Sharefor the six months ended in Dec. 2024 was kr0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00.

During the past 13 years, QUIA PHARMA AB's highest 3-Year average Revenue per Share Growth Rate was 20.80% per year. The lowest was -60.70% per year. And the median was -10.50% per year.

Back to Basics: PS Ratio


QUIA PHARMA AB PS Ratio Historical Data

The historical data trend for QUIA PHARMA AB's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QUIA PHARMA AB PS Ratio Chart

QUIA PHARMA AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.86 - - - -

QUIA PHARMA AB Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of QUIA PHARMA AB's PS Ratio

For the Biotechnology subindustry, QUIA PHARMA AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QUIA PHARMA AB's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, QUIA PHARMA AB's PS Ratio distribution charts can be found below:

* The bar in red indicates where QUIA PHARMA AB's PS Ratio falls into.


;
;

QUIA PHARMA AB PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

QUIA PHARMA AB's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.0133/0.004
=3.33

QUIA PHARMA AB's Share Price of today is kr0.0133.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. QUIA PHARMA AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


QUIA PHARMA AB  (OSTO:QUIA) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


QUIA PHARMA AB PS Ratio Related Terms

Thank you for viewing the detailed overview of QUIA PHARMA AB's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


QUIA PHARMA AB Business Description

Traded in Other Exchanges
Address
Virdings Alle 32 B, Uppsala, SWE, 754 50
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.

QUIA PHARMA AB Headlines

No Headlines